Skip to content

BioTempero

With the successful proof of principle tests at the University Hospital in Tübingen, we have taken the next step towards licensing BioTempero and are thus right on schedule. Clinical validation will take place over the next few months.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Somapharm News

Our Clients